MoneyWorks4Me

Sanofi India informs about disclosure

29 Nov 2023 Evaluate

With reference to its earlier communication dated 17 November 2023, informing about the filing of an application before the Hon’ble NCLT, Mumbai Bench, seeking rectification of an apparent error in the order dated 9 November 2022, by which order, the company was directed to convene meeting of its equity shareholders and unsecured creditors, to consider the scheme of arrangement (‘Order’). In this regard, Sanofi India has informed that the Hon’ble NCLT, Mumbai Bench vide order dated 24 November 2023 has rectified the error by fixing the appointed date of the scheme as to 1 June 2023. A copy of the order dated 24 November 2023 as uploaded on the website of the NCLT is enclosed. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..